Feb 14, 2017 12:03 pm UTC| Business
Divestiture – Sold equipment finance platform and related assets for $105 million in cash, or approximately 1.2x allocated book value, net of debt repayment, transactions fees and other retained liabilities. The...
Feb 14, 2017 12:03 pm UTC| Business
Divestiture – Sold equipment finance platform and related assets for $105 million in cash, or approximately 1.2x allocated book value, net of debt repayment, transactions fees and other retained liabilities. The...
Feb 14, 2017 12:03 pm UTC| Business
- Members of Actinium’s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’s Iomab-B drug candidate to the bone marrow transplant community - BMT...
Feb 14, 2017 12:03 pm UTC| Business
- Members of Actinium’s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’s Iomab-B drug candidate to the bone marrow transplant community - BMT...
Feb 14, 2017 12:03 pm UTC| Business
- Members of Actinium’s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’s Iomab-B drug candidate to the bone marrow transplant community - BMT...
Feb 14, 2017 12:03 pm UTC| Business
- Members of Actinium’s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’s Iomab-B drug candidate to the bone marrow transplant community - BMT...
AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
Feb 14, 2017 12:03 pm UTC| Business
Recently approved first-of-its-kind, non-estrogen prescription therapy for a common symptom of menopause ...